Why don't fistulas mature?

被引:261
作者
Dixon, B. S.
机构
[1] Univ Iowa, Sch Med, Div Nephrol, Iowa City, IA 52242 USA
[2] Vet Affairs Med Ctr, Iowa City, IA 52242 USA
关键词
hemodialysis; arteriovenous fistula; survival; stenosis; blood flow;
D O I
10.1038/sj.ki.5001747
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Fistula maturation requires a compliant and responsive vasculature capable of dilating in response to the increased velocity of blood flowing into the newly created low-resistance circuit. Successful maturation to a high volume flow circuit capable of sustaining hemodialysis typically occurs within the first few weeks after creation. Failure to achieve maturation within 4-8 weeks should prompt a search for reversible etiologies; however, an accepted definition of maturation, particularly for patients not yet on dialysis remains elusive. The most commonly identified etiology is neointimal hyperplasia typically occurring in the juxta-anastomotic vein. However, failed maturation has also been reported secondary to impaired arterial and venous dilation and accessory veins. The exact frequency of each of these etiologies is unclear. Understanding the etiologies of impaired fistula maturation will focus future studies of targeted interventions to improve the rate of fistula maturation and increase the number of dialysis patients with a functioning autogenous fistula.
引用
收藏
页码:1413 / 1422
页数:10
相关论文
共 103 条
  • [21] PATHOPHYSIOLOGY OF VEIN GRAFT FAILURE - A REVIEW
    DAVIES, MG
    HAGEN, PO
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1995, 9 (01) : 7 - 18
  • [22] BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure
    Davies, MR
    Lund, RJ
    Hruska, KA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06): : 1559 - 1567
  • [23] Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling
    de Kleijn, DPV
    Sluijter, JPG
    Smit, J
    Velema, E
    Richard, W
    Schoneveld, AH
    Pasterkamp, G
    Borst, C
    [J]. FEBS LETTERS, 2001, 501 (01) : 37 - 41
  • [24] Design of the Dialysis Access Consortium (DAC) clopidogrel prevention of early AV fistula thrombosis trial
    Dember, LM
    Kaufman, JS
    Beck, GJ
    Dixon, BS
    Gassman, JJ
    Greene, T
    Himmelfarb, J
    Hunsicker, LG
    Kusek, JW
    Lawson, JH
    Middleton, JP
    Rodeva, M
    Schwab, SJ
    Whiting, JF
    Feldman, HI
    [J]. CLINICAL TRIALS, 2005, 2 (05) : 413 - 422
  • [25] Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial
    Dixon, BS
    Beck, GJ
    Dember, LM
    Depner, TA
    Gassman, JJ
    Greene, T
    Himmelfarb, J
    Hunsicker, LG
    Kaufman, JS
    Lawson, JH
    Meyers, CM
    Middleton, JP
    Radeva, M
    Schwab, SJ
    Whiting, JF
    Feldman, HI
    [J]. CLINICAL TRIALS, 2005, 2 (05) : 400 - 412
  • [26] Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula
    Dixon, BS
    Novak, L
    Fangman, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (01) : 92 - 101
  • [27] MECHANICAL AND HISTOLOGIC-CHANGES IN CANINE VEIN GRAFTS
    DOBRIN, PB
    LITTOOY, FN
    GOLAN, J
    BLAKEMAN, B
    FAREED, J
    [J]. JOURNAL OF SURGICAL RESEARCH, 1988, 44 (03) : 259 - 265
  • [28] INCIDENCE OF THE RADIAL STEAL SYNDROME IN PATIENTS WITH BRESCIA FISTULA FOR HEMODIALYSIS - ITS CLINICAL-SIGNIFICANCE
    DUNCAN, H
    FERGUSON, L
    FARIS, I
    [J]. JOURNAL OF VASCULAR SURGERY, 1986, 4 (02) : 144 - 147
  • [29] EJERBLAD S, 1979, ACTA CHIR SCAND, V145, P415
  • [30] Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule
    Fliser, D
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (02) : 71 - 79